Understanding the risk of recurrence after resection of intraductal papillary mucinous neoplasm-associated adenocarcinoma: insights from a large multicenter study.
作者信息
Lin Hong T, Krishna Somashekar G
机构信息
Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
出版信息
Hepatobiliary Surg Nutr. 2024 Dec 1;13(6):1041-1044. doi: 10.21037/hbsn-24-583. Epub 2024 Nov 8.
Abstract
摘要
相似文献
1
Understanding the risk of recurrence after resection of intraductal papillary mucinous neoplasm-associated adenocarcinoma: insights from a large multicenter study.了解导管内乳头状黏液性肿瘤相关腺癌切除术后的复发风险：来自一项大型多中心研究的见解。
Hepatobiliary Surg Nutr. 2024 Dec 1;13(6):1041-1044. doi: 10.21037/hbsn-24-583. Epub 2024 Nov 8.
2
Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma.新辅助化疗治疗浸润性导管内乳头状黏液性肿瘤与新发胰腺腺癌的结果比较。
Ann Surg Oncol. 2024 Apr;31(4):2632-2639. doi: 10.1245/s10434-023-14875-5. Epub 2024 Feb 6.
3
Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.伴有浸润性癌的导管内乳头状黏液性肿瘤与胰腺导管腺癌相关的导管内乳头状黏液性肿瘤的疾病谱：浸润性 IPMN 与胰腺导管腺癌相关的 IPMN。
Pancreas. 2013 Nov;42(8):1267-74. doi: 10.1097/mpa.0b013e3182954137.
4
Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: An International Multicenter Study.导管内乳头状黏液性肿瘤衍生胰腺癌的最佳治疗策略：早期复发的定义与预测——一项国际多中心研究
Ann Surg Oncol. 2025 Mar;32(3):1879-1886. doi: 10.1245/s10434-024-16649-z. Epub 2024 Dec 12.
5
Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.评估胰腺导管腺癌和导管内乳头状黏液性肿瘤中 SOX9 的表达。
Pancreas. 2013 Apr;42(3):488-93. doi: 10.1097/MPA.0b013e318269d281.
6
Outcome after surgery for invasive intraductal papillary mucinous neoplasia compared to conventional pancreatic ductal adenocarcinoma - A Swedish nationwide register-based study.与传统胰腺导管腺癌相比，浸润性导管内乳头状黏液性肿瘤手术后的结局——一项基于瑞典全国登记的研究
Pancreatology. 2023 Jan;23(1):90-97. doi: 10.1016/j.pan.2022.12.003. Epub 2022 Dec 8.
7
Invasive intraductal oncocytic papillary neoplasms (IOPN) and adenocarcimoma arising from intraductal papillary mucinous neoplasms (A-IPMN) of the pancreas: comparative analysis of clinicopathological features, patterns of recurrence and survival: a multicentre study.胰腺浸润性导管内嗜酸细胞性乳头状肿瘤（IOPN）和导管内乳头状黏液性肿瘤（A-IPMN）衍生的腺癌：临床病理特征、复发模式和生存的比较分析：一项多中心研究。
HPB (Oxford). 2024 Nov;26(11):1421-1428. doi: 10.1016/j.hpb.2024.07.410. Epub 2024 Jul 20.
8
Impact of spatio-temporal recurrence pattern on overall survival for invasive intraductal papillary mucinous neoplasia - A comparison with pancreatic ductal adenocarcinoma.空间-时间复发模式对浸润性导管内乳头状黏液性肿瘤总生存的影响 - 与胰腺导管腺癌的比较。
Pancreatology. 2022 Jun;22(5):598-607. doi: 10.1016/j.pan.2022.04.007. Epub 2022 Apr 15.
9
The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).胰腺浸润性导管内乳头状黏液性肿瘤（IPMN）辅助治疗的疗效。
Cancer. 2016 Feb 15;122(4):521-33. doi: 10.1002/cncr.29803. Epub 2015 Nov 20.
10
Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study).导管内乳头状黏液性肿瘤（IPMN）相关腺癌手术切除后的复发风险、分布模式及治疗：一项国际多中心观察性研究（ADENO - IPMN研究）
Ann Surg. 2024 Jul 1;280(1):126-135. doi: 10.1097/SLA.0000000000006144. Epub 2023 Oct 24.
引用本文的文献
1
Surgical Intervention and Prognosis of Intraductal Papillary Mucinous Adenoma in Elderly Patients: A Single Center Retrospective Study.老年患者导管内乳头状黏液性腺瘤的手术干预与预后：一项单中心回顾性研究
Aging Med (Milton). 2025 May 13;8(3):221-228. doi: 10.1002/agm2.70022. eCollection 2025 Jun.
本文引用的文献
1
Recurrence pattern and its risk factors in patients with resected pancreatic ductal adenocarcinoma - A retrospective analysis of 272 patients.切除术后胰腺导管腺癌患者的复发模式及其危险因素：272 例回顾性分析。
Pancreatology. 2024 Sep;24(6):930-937. doi: 10.1016/j.pan.2024.07.017. Epub 2024 Aug 2.
2
Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study).导管内乳头状黏液性肿瘤（IPMN）相关腺癌手术切除后的复发风险、分布模式及治疗：一项国际多中心观察性研究（ADENO - IPMN研究）
Ann Surg. 2024 Jul 1;280(1):126-135. doi: 10.1097/SLA.0000000000006144. Epub 2023 Oct 24.
3
Long-Term Outcomes and Risk of Pancreatic Cancer in Intraductal Papillary Mucinous Neoplasms.导管内乳头状黏液性肿瘤的长期预后和胰腺癌风险。
JAMA Netw Open. 2023 Oct 2;6(10):e2337799. doi: 10.1001/jamanetworkopen.2023.37799.
4
Risk factors for early recurrence in patients with pancreatic ductal adenocarcinoma who underwent curative resection.胰导管腺癌患者根治性切除术后早期复发的危险因素。
World J Surg Oncol. 2023 Aug 24;21(1):263. doi: 10.1186/s12957-023-03141-3.
5
Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline.辅助化疗和放疗在切除的胰腺导管腺癌中的应用：系统评价和临床实践指南。
Curr Oncol. 2023 Jul 8;30(7):6575-6586. doi: 10.3390/curroncol30070482.
6
Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study.胰十二指肠切除术后胰腺导管腺癌的早期和晚期复发模式：一项多中心研究。
Int J Surg. 2023 Apr 1;109(4):785-793. doi: 10.1097/JS9.0000000000000296.
7
Radiofrequency Ablation Remodels the Tumor Microenvironment and Promotes Neutrophil-Mediated Abscopal Immunomodulation in Pancreatic Cancer.射频消融重塑肿瘤微环境并促进胰腺癌中中性粒细胞介导的远隔免疫调节。
Cancer Immunol Res. 2023 Jan 3;11(1):4-12. doi: 10.1158/2326-6066.CIR-22-0379.
8
Impact of Endoluminal Radiofrequency Ablation on Immunity in Pancreatic Cancer and Cholangiocarcinoma.腔内射频消融对胰腺癌和胆管癌免疫的影响
Biomedicines. 2022 Jun 6;10(6):1331. doi: 10.3390/biomedicines10061331.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data.基于真实世界数据的胰腺导管腺癌实际 5 年幸存者。
Sci Rep. 2020 Oct 2;10(1):16425. doi: 10.1038/s41598-020-73525-y.
Zotero 插件